Work

Improving efficacy of in vivo therapy of sickle cell disease by hijacking natural biology of hematopoietic stem cells

Year: 2024

Type: article

Abstract: Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.

Source: Molecular Therapy

DOI: 10.1016/j.ymthe.2024.11.007

Authors: Jia Yao, Dmitry M. Shayakhmetov

Institutions: Emory University, Winship Cancer Institute

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,900